BridgeBio Pharma, Inc. (BBIO) has seen some recent movement in the market and its shares closed at $38.63 yesterday. Traders are starting to take interest of BBIO as the shares traded as high as $39.67 and as low as $38.40 in the last market session.
BridgeBio Pharma, Inc. (BBIO) average trading volume is 647.55K. However, in the last market session BridgeBio Pharma, Inc. (BBIO) exchanged 393,327 shares. The 1st support level on BBIO is $38.27 and the 1st upside resistance level on BBIO is $42.16. BBIO 50 day moving average is $38.51 and BBIO two hundred day moving average is $32.48.
BridgeBio Pharma, Inc. (BBIO) most current performance has been specified by the recent movement in BBIO shares. BBIO has performed 4.12% over the past 30 days, BBIO has performed 30.02% over the past 90 days and BBIO has shown 93.15% over the past 12 months. BridgeBio Pharma, Inc. (BBIO) has a 12 month range of $14.23 to $48.36. BridgeBio Pharma, Inc. (BBIO) is trading 171.47% from its 12 month low and -20.12% from its 12 month high. BridgeBio Pharma, Inc. (BBIO) is displaying a 15.14% short float displaying the quantity short in the float.
BBIO has 117.01M shares outstanding and 70.32M shares in the float. BridgeBio Pharma, Inc. (BBIO) presently has a market cap of $4.80B and income of -346.30M. The EPS next quarter for BBIO is -0.92 and anticipated EPS next year is 9.40%. The market cap of BridgeBio Pharma, Inc. (BBIO) at $4.80B represents how many Traders own shares of BBIO and is based off the last price ($38.63) of BBIO and the quantity of shares outstanding (117.01M) with BridgeBio Pharma, Inc. (BBIO).
BridgeBio Pharma, Inc. (BBIO) has total cash (mrq) of 840.94M, total cash per share (mrq) of 6.87, total debt of BBIO stands at 479.3M and total debt/equity (mrq) is 146.35. . BridgeBio Pharma, Inc. (BBIO) running cash flow (ttm) is -297.97M, BBIO leveraged free cash flow (ttm) is -157.92M.
BBIO is trading -2.18% below (bearish) its SMA20, 8.27% above (bullish) its SMA50 and 21.86% above (bullish) its SMA200.